| Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng, S Luo, Z Li, P Liu, J Han, ... Pharmacological reviews 73 (3), 924-967, 2021 | 486 | 2021 |
| Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation D Kamato, ML Burch, TJ Piva, HB Rezaei, MA Rostam, S Xu, W Zheng, ... Cellular signalling 25 (10), 2017-2024, 2013 | 313 | 2013 |
| Structure, function, pharmacology, and therapeutic potential of the G protein, Gα/q, 11 D Kamato, L Thach, R Bernard, V Chan, W Zheng, H Kaur, M Brimble, ... Frontiers in Cardiovascular Medicine 2, 129046, 2015 | 130 | 2015 |
| Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics S Xu, D Kamato, PJ Little, S Nakagawa, J Pelisek, ZG Jin Pharmacology & therapeutics 196, 15-43, 2019 | 120 | 2019 |
| Endothelial function and dysfunction: Impact of metformin A Nafisa, SG Gray, Y Cao, T Wang, S Xu, FH Wattoo, M Barras, N Cohen, ... Pharmacology & therapeutics 192, 150-162, 2018 | 111 | 2018 |
| GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential X Ma, Z Liu, I Ilyas, PJ Little, D Kamato, A Sahebka, Z Chen, S Luo, ... International journal of biological sciences 17 (8), 2050, 2021 | 100 | 2021 |
| Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics Z Liu, X Ma, I Ilyas, X Zheng, S Luo, PJ Little, D Kamato, A Sahebkar, ... Theranostics 11 (9), 4502, 2021 | 78 | 2021 |
| Animal models for assessing the impact of natural products on the aetiology and metabolic pathophysiology of Type 2 diabetes M Asrafuzzaman, Y Cao, R Afroz, D Kamato, S Gray, PJ Little Biomedicine & Pharmacotherapy 89, 1242-1251, 2017 | 77 | 2017 |
| Treatment of atherosclerotic plaque: perspectives on theranostics Y Zhang, A Koradia, D Kamato, A Popat, PJ Little, HT Ta Journal of Pharmacy and Pharmacology 71 (7), 1029-1043, 2019 | 67 | 2019 |
| Targeted molecular imaging of cardiovascular diseases by iron oxide nanoparticles KX Vazquez-Prada, J Lam, D Kamato, ZP Xu, PJ Little, HT Ta Arteriosclerosis, Thrombosis, and Vascular Biology 41 (2), 601-613, 2021 | 59 | 2021 |
| Activatable magnetic resonance nanosensor as a potential imaging agent for detecting and discriminating thrombosis HT Ta, N Arndt, Y Wu, HJ Lim, S Landeen, R Zhang, D Kamato, PJ Little, ... Nanoscale 10 (31), 15103-15115, 2018 | 58 | 2018 |
| Gaq proteins: molecular pharmacology and therapeutic potential D Kamato, P Mitra, F Davis, N Osman, R Chaplin, PJ Cabot, R Afroz, ... Cellular and Molecular Life Sciences 74, 1379-1390, 2017 | 58 | 2017 |
| The role of specific Smad linker region phosphorylation in TGF-β mediated expression of glycosaminoglycan synthesizing enzymes in vascular smooth muscle MA Rostam, D Kamato, TJ Piva, W Zheng, PJ Little, N Osman Cellular Signalling 28 (8), 956-966, 2016 | 55 | 2016 |
| Endothelial dysfunction and cardiovascular disease: History and analysis of the clinical utility of the relationship PJ Little, CD Askew, S Xu, D Kamato Biomedicines 9 (6), 699, 2021 | 48 | 2021 |
| The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier D Kamato, MA Rostam, R Bernard, TJ Piva, N Mantri, D Guidone, ... Cellular and molecular life sciences 72, 799-808, 2015 | 45 | 2015 |
| Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle HB Rezaei, D Kamato, G Ansari, N Osman, PJ Little Clinical and Experimental Pharmacology and Physiology 39 (8), 661-667, 2012 | 41 | 2012 |
| Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease Y Zhou, PJ Little, HT Ta, S Xu, D Kamato Pharmacology & Therapeutics 204, 107404, 2019 | 40 | 2019 |
| Transforming growth factor–β1 mediated CHST11 and CHSY1 mRNA expression is ROS dependent in vascular smooth muscle cells R Mohamed, P Dayati, RN Mehr, D Kamato, F Seif, ... Journal of cell Communication and Signaling 13, 225-233, 2019 | 40 | 2019 |
| Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genes D Kamato, L Thach, R Getachew, M Burch, MD Hollenberg, W Zheng, ... Cellular signalling 28 (1), 110-119, 2016 | 40 | 2016 |
| Smad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signalling D Kamato, BH Do, N Osman, BP Ross, R Mohamed, S Xu, PJ Little Cellular and Molecular Life Sciences 77, 243-251, 2020 | 37 | 2020 |
Prof. Peter J. Little AMSchool of Pharmacy, The University of QueenslandVerified email at uq.edu.au
